MegaSyn
Collaborations PharmaceuticalsDrug discovery
MegaSyn is a drug discovery model from Collaborations Pharmaceuticals released in 2022.
About MegaSyn
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
Details
- Provider
- Collaborations Pharmaceuticals
- Task
- Drug discovery
- Released
- 2022-03-07
- Open weights
- No